Invest-NL invests EUR 5 million in Xeltis’ EUR 20.5 million funding round

• Invest-NL invested EUR 5 million in a EUR 20.5 million private financing round for Xeltis on July 28, 2026.
• Xeltis is an Eindhoven-based medtech developer of regenerative vascular implants designed to create new blood vessels inside the body.
• Proceeds target wider European rollout of aXess, a dialysis access implant, alongside production scale-up and ongoing U.S. research.
• The round was led by Horizon 3 Healthcare, with other participants including the European Innovation Council and existing shareholders.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invest-NL NV published the original content used to generate this news brief on July 28, 2026, and is solely responsible for the information contained therein.